30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Exactech Reports 2Q16 Revenue -

Exactech (EXAC) reported 2Q16 revenue of US $66.1MM, +7.5% from 2Q15. (U.S. $44.6MM, +8.0%; ex-U.S. $21.5MM, +6.4%) All growth is as reported. 

ORTHOWORLD estimates 1Q16 segment sales and growth on an as-reported basis, as follows.

  • Joint Reconstruction $60.7MM, +9.2% (Includes Other revenue attributed to subsegments)
    • Hips $13.3MM, +11.6%
    • Knees $21.1MM, -0.1%
    • Extremities Recon $26.3MM, +16.5%
  • Spine $2.3MM, -14.8%
  • Orthobiologics $3.1MM, -2.3%


This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.